‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMixed Topics
FDA approves olaparib for certain metastatic prostate cancersMay 21, 2020Genitourinary CancerProstate CancerOncology
First PARP inhibitor approved for metastatic prostate cancerMay 19, 2020Genitourinary CancerProstate CancerOncology
ASCO goes ahead online, as conference center is used as hospitalMay 11, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
COVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Three months of COVID-19 may mean 80,000 missed cancer diagnosesMay 4, 2020Breast CancerGenitourinary CancerLung CancerOncology
Cancer screening, monitoring down during pandemicMay 4, 2020Breast CancerGenitourinary CancerLung CancerMelanomaOncology
Excess cancer deaths predicted as care is disrupted by COVID-19May 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Antitumor treatment may increase risk of severe events in COVID-19 patientsMay 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerOncology
ASCO panel outlines cancer care challenges during COVID-19 pandemicApril 27, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Will coronavirus restrictions lead to more advanced cancers?April 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
European cancer centers restructure care in the era of COVID-19April 22, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Want to keep cancer patients and providers safe during the pandemic? Here’s howApril 20, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
